PubRank

S G Pauker

Author PubWeight™ 182.91‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The threshold approach to clinical decision making. N Engl J Med 1980 8.51
2 On the elicitation of preferences for alternative therapies. N Engl J Med 1982 7.85
3 Screening for HIV: can we afford the false positive rate? N Engl J Med 1987 5.94
4 Screening for prostate cancer. A decision analytic view. JAMA 1994 5.83
5 Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 1981 4.34
6 Myocardial revascularization for chronic stable angina. Analysis of the role of percutaneous transluminal coronary angioplasty based on data available in 1989. Ann Intern Med 1990 4.32
7 Fallacy of the five-year survival in lung cancer. N Engl J Med 1978 4.23
8 Therapeutic decision making: a cost-benefit analysis. N Engl J Med 1975 3.89
9 Towards the simulation of clinical cognition. Taking a present illness by computer. Am J Med 1976 3.62
10 The Markov process in medical prognosis. Med Decis Making 1983 3.58
11 Decision analysis. N Engl J Med 1987 3.41
12 Contentious screening decisions: does the choice matter? N Engl J Med 1997 3.28
13 Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA 1997 3.18
14 Effect of laboratory variation in the prothrombin-time ratio on the results of oral anticoagulant therapy. N Engl J Med 1993 3.03
15 Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs. JAMA 1999 2.97
16 When should an effective treatment be used? Derivation of the threshold number needed to treat and the minimum event rate for treatment. J Clin Epidemiol 2001 2.84
17 Decision analysis: a progress report. Ann Intern Med 1987 2.82
18 The toss-up. N Engl J Med 1981 2.71
19 Variations in length of stay and outcomes for six medical and surgical conditions in Massachusetts and California. JAMA 1991 2.71
20 A convenient approximation of life expectancy (the "DEALE"). II. Use in medical decision-making. Am J Med 1982 2.56
21 A convenient approximation of life expectancy (the "DEALE"). I. Validation of the method. Am J Med 1982 2.49
22 Deciding about screening. Ann Intern Med 1993 2.36
23 Cost-effectiveness of interferon-alpha 2b treatment for hepatitis B e antigen-positive chronic hepatitis B. Ann Intern Med 1995 2.32
24 Prenatal diagnosis: a directive approach to genetic counseling using decision analysis. Yale J Biol Med 1977 2.28
25 Occult intracranial aneurysms in polycystic kidney disease. When is cerebral arteriography indicated? N Engl J Med 1983 2.12
26 Estimates of the cost-effectiveness of a single course of interferon-alpha 2b in patients with histologically mild chronic hepatitis C. Ann Intern Med 1997 2.09
27 Foot infections in diabetic patients. Decision and cost-effectiveness analyses. JAMA 1995 1.95
28 The epidemiology of delays in a teaching hospital. The development and use of a tool that detects unnecessary hospital days. Med Care 1989 1.91
29 You're never too old. N Engl J Med 1993 1.86
30 Decision analysis and the implementation of research findings. BMJ 1998 1.85
31 The amniocentesis decision: ten years of decision analytic experience. Birth Defects Orig Artic Ser 1987 1.85
32 Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pediatr 1991 1.81
33 Routine preoperative screening for HIV. Does the risk to the surgeon outweigh the risk to the patient? JAMA 1988 1.59
34 Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group. Am J Gastroenterol 2000 1.57
35 The diagnostic importance of the normal finding. N Engl J Med 1978 1.53
36 Bone marrow donor registries: the relation between registry size and probability of finding complete and partial matches. Blood 1989 1.50
37 Mild head trauma in children: When is a roentgenogram Necessary. Pediatrics 1982 1.41
38 A peripartum neurologic event: shooting from the hip. Med Decis Making 1988 1.37
39 Automated critiquing of medical decision trees. Med Decis Making 1989 1.32
40 Pathology and probabilities: a new approach to interpreting and reporting biopsies. N Engl J Med 1981 1.17
41 Coronary artery surgery: the use of decision analysis. Ann Intern Med 1976 1.14
42 Clinical decision analysis by personal computer. Arch Intern Med 1981 1.13
43 The economic impact of acute variceal bleeding: cost-effectiveness implications for medical and surgical therapy. Surgery 1980 1.10
44 Isoniazid for the tuberculin reactor: take it or leave it. Am Rev Respir Dis 1988 1.06
45 What is a good decision? Eff Clin Pract 1999 1.05
46 Clinical decision consultation service. Am J Med 1986 1.04
47 The decision to biopsy, treat, or wait in suspected herpes encephalitis. Ann Intern Med 1980 1.04
48 Antithrombotic therapy in valvular heart disease. Chest 2001 1.02
49 Cost-effectiveness of streptokinase for acute myocardial infarction: A combined meta-analysis and decision analysis of the effects of infarct location and of likelihood of infarction. Med Decis Making 1994 1.00
50 Tocainide-associated interstitial pneumonitis. Ann Intern Med 1981 1.00
51 Impact of patient preferences on the selection of therapy. J Chronic Dis 1981 0.99
52 The amniocentesis decision: an explicit guide for parents. Birth Defects Orig Artic Ser 1979 0.97
53 Recurrent deep venous thrombosis in pregnancy. Analysis of the risks and benefits of anticoagulation. Med Decis Making 1981 0.96
54 Medical informatics: where the action is. West J Med 1997 0.96
55 Cost-effectiveness of therapies for patients with nonvalvular atrial fibrillation. Arch Intern Med 1998 0.95
56 Capturing clinical expertise. A computer program that considers clinical responses to digitalis. Am J Med 1978 0.94
57 Clinical application of decision analysis: a detailed illustration. Semin Nucl Med 1978 0.93
58 Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. Endocrinol Metab Clin North Am 1990 0.91
59 The relative value of carotid noninvasive testing as determined by receiver operator characteristic curves. Surgery 1980 0.90
60 Prenatal diagnosis--why is 35 a magic number? N Engl J Med 1994 0.90
61 The mean interval to conception: a measure of utility for the analysis of decisions involving fertility. Am J Obstet Gynecol 1989 0.90
62 Endarterectomy in carotid artery disease. A decision analysis. JAMA 1987 0.88
63 Using observational data to estimate prognosis: an example using a coronary artery disease registry. Stat Med 2001 0.88
64 How do physicians weigh iatrogenic complications? J Gen Intern Med 1994 0.88
65 Elective pericardiectomy for tuberculous pericarditis: should the snappers be snipped? Med Decis Making 1986 0.86
66 The effect of private attitudes on public policy. Prenatal screening for neural tube defects as a prototype. Med Decis Making 1981 0.86
67 Glaucoma screening. A cost-effectiveness analysis. Surv Ophthalmol 1984 0.86
68 Decision Maker 3.0. Improved decision analysis by personal computer. Med Decis Making 1983 0.86
69 What to do when the patient outlives the literature, or DEALE-ing with a full deck. Med Decis Making 1983 0.86
70 Evaluation for colon cancer in patients with occult fecal blood loss while taking aspirin: a Bayesian viewpoint. Med Decis Making 1982 0.85
71 Postmenopausal estrogens in prevention of osteoporosis. Benefit virtually without risk if cardiovascular effects are considered. Am J Med 1986 0.85
72 The patient's role in assessing the value of diagnostic tests. Radiology 1979 0.84
73 Supporting statements and rationale. J Gerontol 1992 0.84
74 Cost-effectiveness of the implantable cardioverter-defibrillator: effect of improved battery life and comparison with amiodarone therapy. J Am Coll Cardiol 1992 0.84
75 Decision analysis for public health: principles and illustrations. Annu Rev Public Health 1984 0.84
76 The cold thyroid nodule: an analysis of diagnostic and therapeutic options. Endocr Rev 1984 0.83
77 Editorial: Coronary surgery: when, where and for whom? N Engl J Med 1975 0.83
78 Making decisions about antithrombotic therapy in heart disease: decision analytic and cost-effectiveness issues. Chest 1998 0.83
79 Cost effectiveness of ribavirin/interferon alfa-2b after interferon relapse in chronic hepatitis C. Am J Med 2000 0.82
80 Prostatic cancer in a patient with asymptomatic HIV infection: are some lives more equal than others? Med Decis Making 1988 0.82
81 Cost-effectiveness of radiofrequency ablation compared with other strategies in Wolff-Parkinson-White syndrome. Circulation 1993 0.81
82 Local effects of electrical and mechanical stimulation on the recovery properties of the canine ventricle. Am J Cardiol 1982 0.81
83 Should diagnostic testing be regulated? N Engl J Med 1978 0.81
84 Clinical problem-solving. A little math helps the medicine go down. N Engl J Med 1999 0.81
85 Cost-effectiveness of antibiotic prophylaxis for dental procedures in patients with artificial joints. Am J Public Health 1989 0.80
86 Lengths of stay of patients with uncomplicated acute myocardial infarction at three Boston hospitals: impact of pre-discharge tactics. J Gen Intern Med 1988 0.80
87 Decision analysis in clinical cardiology: when is coronary angiography required in aortic stenosis? J Am Coll Cardiol 1990 0.80
88 Repeated syncope with negative diagnostic evaluation. To pace or not to pace? Med Decis Making 1984 0.80
89 Which renal transplant patients should receive cytomegalovirus immune globulin? A cost-effectiveness analysis. Transplantation 1991 0.80
90 Making decisions about antithrombotic therapy in heart disease. Decision analytic and cost-effectiveness issues. Chest 1995 0.79
91 The utility of thresholds and the threshold utility. Med Decis Making 1988 0.79
92 Modeling therapeutic benefit in the midst of uncertainty: therapy for hepatitis C. Dig Dis Sci 1996 0.79
93 Direct angioplasty for acute myocardial infarction. A review of outcomes in clinical subsets. Ann Intern Med 1992 0.79
94 Decision analysis as a basis for medical decision making: the tree of hippocrates. J Med Philos 1984 0.79
95 Whose blood is safer? The effect of the stage of the epidemic on screening for HIV. Med Decis Making 1997 0.78
96 Prescriptive models to support decision making in genetics. Birth Defects Orig Artic Ser 1987 0.78
97 Warfarin for dilated cardiomyopathy: a bloody tough pill to swallow? Med Decis Making 1989 0.78
98 Individualizing therapy to prevent long-term consequences of estrogen deficiency in postmenopausal women. Arch Intern Med 1999 0.78
99 Sequential unipolar strength-interval curves and conduction times during myocardial ischemia and reperfusion in the dog. Circ Res 1978 0.78
100 Antithrombotic therapy in valvular heart disease. Chest 1986 0.78
101 Grand-rounds whiplash. N Engl J Med 1970 0.77
102 Antithrombotic therapy in valvular heart disease. Chest 1989 0.77
103 Technology assessment in health care: group process and decision theory. Isr J Med Sci 1986 0.77
104 Influence diagrams: a new dimension for decision models. Med Decis Making 1997 0.77
105 Cytomegalovirus immune globulin after liver transplantation: a cost-effectiveness analysis. Clin Transplant 2000 0.77
106 Task Force I: Determination of prognosis in patients with ischemic heart disease. J Am Coll Cardiol 1989 0.77
107 Anticoagulation for noncardiac procedures in patients with prosthetic heart valves. Does low risk mean high cost? JAMA 1990 0.77
108 Elective surgery in the setting of comorbid anesthesia risk. Timing of cholecystectomy in a patient with Graves' disease and hepatitis. Med Decis Making 1982 0.76
109 Aortic aneurysm in a 74-year-old man with coronary disease and obstructive lung disease: is double jeopardy enough? Med Decis Making 1989 0.76
110 Impact of postmenopausal hormone therapy on cardiovascular events and cancer. Study's conclusions were incorrect. BMJ 1997 0.76
111 Antithrombotic therapy in valvular heart disease. Chest 1992 0.76
112 Clinical decision analysis using microcomputers. A case of coexistent hepatocellular carcinoma and abdominal aortic aneurysm. West J Med 1986 0.76
113 Antithrombotic therapy in valvular heart disease. Chest 1998 0.76
114 DecisionNET: database/network support for clinical decision analysts. Ann N Y Acad Sci 1992 0.76
115 Cost effectiveness of oral as compared with intravenous antibiotic therapy for patients with early Lyme disease or Lyme arthritis. N Engl J Med 1997 0.76
116 The isoniazid debate. Arch Intern Med 1991 0.75
117 Does DEALE-ing stack the deck? Med Decis Making 1999 0.75
118 Decision Tool--a graphical user interface for generic Markov models. Proc Annu Symp Comput Appl Med Care 1994 0.75
119 Finding what you seek: analyzing therapies for nonvalvular atrial fibrillation. Ann Intern Med 1999 0.75
120 Clinical impact of inaccuracies in anticoagulation monitoring. Arch Intern Med 1995 0.75
121 A patient with new Q waves: methods for decision making in the individual patient. J Am Coll Cardiol 1989 0.75
122 Anticoagulation and atrial fibrillation in the bradycardia-tachycardia syndrome. Med Decis Making 1981 0.75
123 Preferences of patients and the fallacy of the five-year survival. N Engl J Med 1979 0.75
124 Enhanced hepatic uptake of thallium-201 in patients with severe narrowing of the right coronary artery. Am J Cardiol 1995 0.75
125 HIV screening: nosocomial epidemiologic risks and decision analysis. Law Med Health Care 1990 0.75
126 Therapeutic controversy: Hormone replacement therapy--where are we going? J Clin Endocrinol Metab 1999 0.75
127 The timing of radical cystectomy after recent myocardial infarction: waiting for Godot. Med Decis Making 1987 0.75
128 Abdominal pain, atherosclerosis, and atrial fibrillation. The case for mesenteric ischemia. Med Decis Making 1982 0.75
129 Idiopathic nephrotic syndrome. Puncturing the biopsy myth. Ann Intern Med 1987 0.75
130 The need to identify patients who have received streptokinase therapy. N Engl J Med 1991 0.75
131 Recurrent deep venous thrombosis in pregnancy. Med Decis Making 1982 0.75
132 Use of decision analysis in a complicated case of renovascular hypertension. Hypertension 1988 0.75
133 Idiopathic nephrotic syndrome in a 53-year-old woman. Is a kidney biopsy necessary? Med Decis Making 1982 0.75
134 Whether or not to administer Amphotericin to an immunosuppressed patient with hematologic malignancy and undiagnosed fever. Med Decis Making 1981 0.75
135 An ambiguous renal cyst in a patient with a prior nephrectomy: what to do when there is only one more to lose. Med Decis Making 1986 0.75
136 A computer-based Markov decision analysis of the management of symptomatic bifascicular block: the threshold probability for pacing. J Am Coll Cardiol 1987 0.75
137 A ten-year-old boy with cerebral palsy and femoral anteversion. How much does it hurt to break a leg? Med Decis Making 1984 0.75
138 Decision analysis as a synthetic tool for achieving consensus in technology assessment. Int J Technol Assess Health Care 1986 0.75
139 Symposium: The role of decision analysis in medical education and practice. Annu Conf Res Med Educ 1979 0.75
140 Transient ischemic attacks in a man with coronary artery disease: two strategies neck and neck. Med Decis Making 1986 0.75
141 Enterococcal endocarditis and penicillin allergy. Which drug for the bug? Med Decis Making 1983 0.75
142 Human immunodeficiency virus infection in health care workers. A method for estimating individual occupational risk. Arch Intern Med 1989 0.75
143 A decision analytic view of anticoagulant prophylaxis for thromboembolism in heart disease. Chest 1986 0.75
144 Letter: The diagnostic use of clinical findings. JAMA 1976 0.75
145 Decision analytic and cost-effectiveness issues concerning anticoagulant prophylaxis in heart disease. Chest 1992 0.75
146 Eaton-Lambert syndrome and small cell lung cancer: side effects and certainty. Med Decis Making 1986 0.75
147 Competing rates of risk in a patient with subarachnoid hemorrhage and myocardial infarction: it's now or never. Med Decis Making 1988 0.75
148 Twisted sisters: when is the optimal tme for delivery? Med Decis Making 1990 0.75
149 A 65-year-old Chinese woman with lymphadenopathy and progressive pulmonary infiltrates. One million Chinese women can't all have tuberculosis. Med Decis Making 1981 0.75
150 Decision analysis for isoniazid preventive therapy: take it or leave it? Am Rev Respir Dis 1988 0.75
151 Recurrent endocarditis in a patient with a permanent transvenous pacemaker. Med Decis Making 1982 0.75
152 Bilateral pulmonary infiltrates in an 11-year-old with acute lymphocytic leukemia. Is a chance to cut really a chance to cure? Med Decis Making 1983 0.75
153 Kidney failure or cancer. Should immunosuppression be continued in a transplant patient with malignant melanoma? Med Decis Making 1984 0.75
154 A coherent philosophy for development or a straightjacket for research? Methods Inf Med 1993 0.75
155 HLA-matched donor registries for bone marrow transplants. A decision analysis. Int J Technol Assess Health Care 1986 0.75
156 The rapid generation of strength-interval curves under computer control. Comput Programs Biomed 1979 0.75
157 Surgical therapy for coronary artery disease: Caveat emptor. Am Heart J 1977 0.75
158 Antithrombotic therapy in valvular heart disease. Chest 1995 0.75
159 Word processing, phase III. MD Comput 1987 0.75
160 Double trouble: a patient with two prosthetic valves and two episodes of intracranial bleeding. Med Decis Making 1987 0.75